-0.70 | -2.02%
| Price and Volume | |
|---|---|
| Recent Price | 34.51 |
| 52 Week High | 40.58 |
| 52 Week Low | 30.98 |
| Avg. Daily Vol. (Mil) | 3.72 |
| Beta (3 year) | 1.04 |
| Share Related Items | |
| Mkt Cap (Mil) | 92,550.22 |
| Shares Out (Mil) | 2,681.84 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 4.90 |
| Annual Dividend | 1.69 |
| Payout Ratio | 48.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.50 |
| LT Debt/ Equity | 0.22 |
| Total Debt / Equity | 0.27 |
| Valuation Ratios | |
| Price Earnings | 12.40 |
| Price/Sales | 2.03 |
| Price/Book | 1.27 |
| Price/Cash Flow | 6.30 |
| Per Share Data | |
| Earnings | 2.78 |
| Sales | 16.97 |
| Book Value | 27.21 |
| Cash Flow | 5.44 |
| Business Summary | |
|---|---|
| Sanofi-aventis is a global pharmaceutical company, which is engaged in the research, development, manufacture and marketing of healthcare products. | |
| General Information | |
| 174, avenue de France
Paris, 75013 |
|
| 1.0 | |
| www.sanofi-aventis.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 113719 | |
| CEO: Christopher Viehbacher | |
| Short Interest | |
| Current Month (Mil) | 15.20 |
| Previous Month (Mil) | 13.41 |
| Short Interest Ratio (Days) | 3.50 |
| Management Effectiveness | |
| Return on Equity | 10.10 |
| Return on Assets | 5.70 |
| Return on Investments | 8.30 |
| Profitability | |
| Gross Margin | 75.30 |
| EBIT Margin | 19.80 |
| Profit Margin | 16.20 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,434.09 | 1,316.10 | 2,842.81 | 16.29 |
Oil *
103.28
|
|
DOWN
146.60 |
DOWN
16.32 |
DOWN
28.18 |
DOWN
1.02 |
10 Yr
1.63%
SPDR Gold
151.98
|
|
-1.17%
|
-1.22%
|
-0.98%
|
-5.89%
|
Data delayed 20 minutes |
Connect with TheStreet